ASX Announcement 18 November 2026 Results of Annual General Meeting Sydney, Australia – 18 November 2026: OncoSil Medical Limited (ASX: OSL), a medical device company focused on localised treatments for patients with unresectable locally advanced pancreatic cancer (LAPC) and distal...
Results of Meeting
Filed with ASX · · 2 pages · English
Summary by 6ix AI
OncoSil Medical Ltd has announced the results of its Annual General Meeting, where all resolutions were carried by poll. The announcement includes details of the proxies received and votes cast for each resolution. This filing was authorized by the Chairman of OncoSil Medical Limited.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Release
In the deck
Earlier from OncoSil Medical
- AGM Chairman's Address and CEO & MD Presentation
- OncoSil to Present at Bell Potter Healthcare Conference 2026
- Regulatory Application Filed for Australian Manufacturing
- Quarterly Activities/Appendix 4C Cash Flow Report
- Annual Report (Typeset)
Later from OncoSil Medical
All OncoSil Medical news releasesFollow OncoSil Medical into a list and get an email when it puts out news.
Follow OncoSil Medical